Type I Interferons in COVID-19 Pathogenesis
- PMID: 34571706
- PMCID: PMC8468334
- DOI: 10.3390/biology10090829
Type I Interferons in COVID-19 Pathogenesis
Abstract
Among the many activities attributed to the type I interferon (IFN) multigene family, their roles as mediators of the antiviral immune response have emerged as important components of the host response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Viruses likewise have evolved multiple immune evasion strategies to circumvent the host immune response and promote virus propagation and dissemination. Therefore, a thorough characterization of host-virus interactions is essential to understand SARS-CoV-2 pathogenesis. Here, we summarize the virus-mediated evasion of the IFN responses and the viral functions involved, the genetic basis of IFN production in SARS-CoV-2 infection and the progress of clinical trials designed to utilize type I IFN as a potential therapeutic tool.
Keywords: COVID-19; SARS-CoV-2; innate immunity; type I IFNs.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- WHO WHO Director-General’s opening remarks at the media briefing on COVID-19, 11 March 2020. 2020. [(accessed on 13 July 2021)]. Available online: https://www.who.int/director-general/speeches/detail/who-director-genera....
-
- WHO WHO Coronavirus (COVID-19) Dashboard. [(accessed on 25 August 2021)]. Available online: https://covid19.who.int/
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
